Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Filings indexed 1,697 across all filing types
Latest filing 2019-09-12 Investor Presentation
Country TW Taiwan
Listing TW 4119

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
108年09月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation files. The content focuses on a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. There is no financial report or regulatory filing content, just information about the presentation event and links to presentation materials. The document length is short (693 characters), and it is clearly an announcement or summary of an investor presentation event rather than the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP).
2019-09-12 Chinese
108年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 旭富製藥科技股份有限公司. It lists shareholdings by directors, independent directors, managers, and other insiders, including pledged shares and shares held by spouses or minors. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not a report or announcement of financial results, nor a regulatory filing about voting or dividends. The content matches the definition of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is about 3,148 characters, which is consistent with a detailed insider shareholding disclosure rather than a full report or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2019-09-11 Chinese
108年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement. The document matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider shareholdings and transactions.
2019-09-11 Chinese
公告本公司於9月12日受日盛證券邀請說明營運概況
Investor Presentation Classification · 95% confidence The document is a short announcement about a scheduled investor presentation (法人說明會) on September 12, 2019, where the company will explain its operational overview. It includes details such as date, time, location, and a brief description of the event. The document does not contain any financial statements or detailed financial data, nor is it a transcript or report itself. It is an announcement of an upcoming investor presentation event. Therefore, the appropriate classification is Investor Presentation (IP). The document length is only 617 characters, indicating it is a brief announcement rather than a full report.
2019-09-11 Chinese
108年8月背書保證與資金貸與
Capital/Financing Update Classification · 95% confidence The document is a brief financial disclosure from a listed company (旭富) providing information about fund lending balances and endorsement guarantees for the current and previous months, with zero amounts reported. The content is concise, factual, and relates to capital or financing status but does not contain detailed financial statements or analysis. It is not a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about financing-related data, fitting best under Capital/Financing Update (CAP). The document length is short and focused on financing data, supporting this classification with high confidence.
2019-09-09 Chinese
108年8月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 旭富, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (773 characters), and it does not appear to be a full financial report but rather a brief financial data disclosure. There is no indication that this is an announcement of a report publication or a certification. The content fits best with a brief financial summary or factsheet type document. Therefore, the most appropriate classification is Fund Information / Factsheet (FS).
2019-09-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.